Multiple sclerosis care is judged not only by diagnosis and access to disease-modifying therapy, but by how well services work together across the whole care pathway.
No takes yet. Share an insight, caveat, or question.
Stross et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: